⌘K

MAIA Biotechnology, Inc. (MAIA)

$2.85 1.79% $0.05 Healthcare

MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.

Market cap

$68.14M

CEO

Dr. Vlad Vitoc M.B.A., M.D.

Full time employees

9.00

Headquarters

Chicago, IL

IPO Date

Jul 28, 2022

Price-to-earnings (PE) Ratio

-1.76

Earnings-per-share (EPS)

$-1.62

Cash ratio (TTM)

3.30

Current ratio (TTM)

3.42

Net profit margin (TTM)

0.00%

PE ratio (TTM)

-2.32

PEG ratio (TTM)

-0.02

Price-to-book ratio (TTM)

20.65

Price-to-sales ratio (TTM)

0.00

Quick ratio (TTM)

3.42

Return on assets (TTM)

-233.61%

Return on equity (TTM)

-18,051.81%

Similar stocks (13)

Larimar Therapeutics, Inc.

LRMR

$7.14 4.23% $0.29

Downtrend

Nautilus Biotechnology, Inc.

NAUT

$3.00 4.53% $0.13

Neutral

Lineage Cell Therapeutics, Inc.

LCTX

$0.91 3.41% $0.03

Downtrend

Genelux Corporation

GNLX

$2.37 -3.27% $-0.08

Downtrend

Armata Pharmaceuticals, Inc.

ARMP

$2.23 6.19% $0.13

Downtrend

Champions Oncology, Inc.

CSBR

$4.89 14.25% $0.61

Downtrend

Dyadic International, Inc.

DYAI

$1.19 2.59% $0.03

Downtrend

Lumos Pharma, Inc.

LUMO

$3.92 5.95% $0.22

Neutral

Lyra Therapeutics, Inc.

LYRA

$0.28 2.67% $0.00

Downtrend

Monopar Therapeutics Inc.

MNPR

$4.50 14.21% $0.56

Neutral

Cingulate Inc.

CING

$5.14 4.05% $0.20

Downtrend

Portage Biotech Inc.

PRTG

$10.21 3.03% $0.30

Downtrend

Comera Life Sciences Holdings, Inc.

CMRA

$0.02 0.00% $0.00

Downtrend

ETF Exposure (6)

iShares Micro-Cap ETF

IWC

0.01064%

$126.54 2.19% $2.71

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.99 -0.24% $-0.33

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$282.05 1.69% $4.70

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.97 -0.24% $-0.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.92 2.00% $3.58

Uptrend

Neutral

Similar stocks (13)

Larimar Therapeutics, Inc.

LRMR

$7.14 4.23% $0.29

Downtrend

Nautilus Biotechnology, Inc.

NAUT

$3.00 4.53% $0.13

Neutral

Lineage Cell Therapeutics, Inc.

LCTX

$0.91 3.41% $0.03

Downtrend

Genelux Corporation

GNLX

$2.37 -3.27% $-0.08

Downtrend

Armata Pharmaceuticals, Inc.

ARMP

$2.23 6.19% $0.13

Downtrend

Champions Oncology, Inc.

CSBR

$4.89 14.25% $0.61

Downtrend

Dyadic International, Inc.

DYAI

$1.19 2.59% $0.03

Downtrend

Lumos Pharma, Inc.

LUMO

$3.92 5.95% $0.22

Neutral

Lyra Therapeutics, Inc.

LYRA

$0.28 2.67% $0.00

Downtrend

Monopar Therapeutics Inc.

MNPR

$4.50 14.21% $0.56

Neutral

Cingulate Inc.

CING

$5.14 4.05% $0.20

Downtrend

Portage Biotech Inc.

PRTG

$10.21 3.03% $0.30

Downtrend

Comera Life Sciences Holdings, Inc.

CMRA

$0.02 0.00% $0.00

Downtrend

ETF Exposure (6)

iShares Micro-Cap ETF

IWC

0.01064%

$126.54 2.19% $2.71

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.99 -0.24% $-0.33

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$282.05 1.69% $4.70

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.97 -0.24% $-0.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.92 2.00% $3.58

Uptrend